A Randomised Phase II Trial of Oral Vinorelbine as Second Line Therapy for Patients With Malignant Pleural Mesothelioma
Phase of Trial: Phase II
Latest Information Update: 14 Apr 2017
At a glance
- Drugs Vinorelbine (Primary)
- Indications Mesothelioma
- Focus Therapeutic Use
- Acronyms VIM
- 07 Apr 2017 Planned End Date changed from 1 Sep 2019 to 1 Dec 2018.
- 07 Apr 2017 Planned primary completion date changed from 1 Dec 2016 to 1 Mar 2018.
- 23 Jan 2017 Status changed from not yet recruiting to recruiting.